Alcon Inc. (ALC)

Health Care

Alcon Inc. (ALC) is listed on the New York Stock Exchange, where its shares have traded since April 9, 2019. SentiSense covers Alcon Inc. in the Health Care sector. David J. Endicott is its chief executive officer. The company reports 25,942 employees, and its corporate website is www.alcon.com.

About Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 614 institutions reported holding ALC, with 233.9 million shares worth $15.7 billion in aggregate. The largest reported holders were Vanguard, BNY Mellon and Norges Bank. Of the 5 largest reported holders, 1 opened a new position in ALC, 2 added shares and 2 reduced their positions during the quarter.

More on ALC

  • ALC sentiment: whether news and social coverage of Alcon Inc. leans bullish or bearish, and the stories driving it.
  • ALC ownership: all 614 reporting institutions, plus insider and congressional trades.
  • ALC financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Alcon Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions

What does Alcon Inc. do?

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019.

What sector is ALC in?

SentiSense classifies Alcon Inc. in the Health Care sector.

Where does ALC stock trade?

Alcon Inc. (ALC) is listed on the New York Stock Exchange, where its shares have traded since April 9, 2019.

Who is the CEO of Alcon Inc.?

David J. Endicott is the chief executive officer of Alcon Inc..